Cohen Cherylinsider trades

In SEC Form 4 filings, Cohen Cheryl is listed as Director of ImmunityBio, Inc. (IBRX). In the last 90 days, Cohen Cheryl sold $851.1K of ImmunityBio, Inc. (IBRX) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
IBRXImmunityBio, Inc.	Director	3	Oct 6

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-06

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
IBRXImmunityBio, Inc.	Oct 2	Oct 6	M	55,979	$2.98	$166,817	181,365	Yes	Form 4
IBRXImmunityBio, Inc.	Oct 2	Oct 6	S	81,056	$10.50	Sale −$851,088	100,309	Yes	Form 4
IBRXImmunityBio, Inc.	Oct 2	Oct 6	M · derivative	55,979	$2.98	$166,817	55,979	Yes	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.